{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,15]],"date-time":"2025-10-15T17:39:46Z","timestamp":1760549986930,"version":"3.37.3"},"reference-count":60,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2016,6,1]],"date-time":"2016-06-01T00:00:00Z","timestamp":1464739200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100014658","name":"Society for the Advancement of Anaesthesia in Dentistry","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100014658","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001632","name":"Ulster University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001632","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Experimental Cell Research"],"published-print":{"date-parts":[[2016,6]]},"DOI":"10.1016\/j.yexcr.2016.04.007","type":"journal-article","created":{"date-parts":[[2016,4,10]],"date-time":"2016-04-10T06:59:59Z","timestamp":1460271599000},"page":"201-209","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"title":["Functionality and antidiabetic utility of \u03b2- and L-cell containing pseudoislets"],"prefix":"10.1016","volume":"344","author":[{"given":"Alastair D.","family":"Green","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Srividya","family":"Vasu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter R.","family":"Flatt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.yexcr.2016.04.007_bib1","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1177\/0115426507022005485","article-title":"Pancreatic islet cell transplantation: update and new developments","volume":"22","author":"Onaca","year":"2007","journal-title":"Nutr. Clin. Pract."},{"key":"10.1016\/j.yexcr.2016.04.007_bib2","doi-asserted-by":"crossref","first-page":"1436","DOI":"10.2337\/dc12-0063","article-title":"Improvement in outcomes of clinical islet transplantation: 1999\u20132010","volume":"35","author":"Barton","year":"2012","journal-title":"Diabetes Care"},{"key":"10.1016\/j.yexcr.2016.04.007_bib3","doi-asserted-by":"crossref","first-page":"a007823","DOI":"10.1101\/cshperspect.a007823","article-title":"Update on islet transplantation","volume":"2","author":"McCall","year":"2012","journal-title":"Cold Spring Harb. Perspect. Med."},{"key":"10.1016\/j.yexcr.2016.04.007_bib4","doi-asserted-by":"crossref","first-page":"21982","DOI":"10.1074\/jbc.M111.226795","article-title":"Development and functional characterization of insulin-releasing human pancreatic beta cell lines produced by electrofusion","volume":"286","author":"McCluskey","year":"2011","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.yexcr.2016.04.007_bib5","doi-asserted-by":"crossref","first-page":"2087","DOI":"10.1172\/JCI72674","article-title":"Development of a conditionally immortalized human pancreatic \u03b2 cell line","volume":"124","author":"Scharfmann","year":"2014","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.yexcr.2016.04.007_bib6","doi-asserted-by":"crossref","DOI":"10.1155\/2012\/382518","article-title":"Exenatide pretreatment improved graft function in nonhuman primate islet recipients compared to treatment after transplant only","author":"Buss","year":"2012","journal-title":"J. Transplant."},{"key":"10.1016\/j.yexcr.2016.04.007_bib7","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1007\/s11892-013-0402-z","article-title":"Use of glucagon-like peptide-1 agonists to improve islet graft performance","volume":"13","author":"Wang","year":"2013","journal-title":"Curr. Diab Rep."},{"key":"10.1016\/j.yexcr.2016.04.007_bib8","doi-asserted-by":"crossref","first-page":"2270","DOI":"10.2337\/diabetes.48.12.2270","article-title":"Exendin-4 stimulates both beta-cell replication and neogenesis, resulting in increased beta-cell mass and improved glucose tolerance in diabetic rats","volume":"48","author":"Xu","year":"1999","journal-title":"Diabetes"},{"key":"10.1016\/j.yexcr.2016.04.007_bib9","doi-asserted-by":"crossref","first-page":"3703","DOI":"10.1210\/endo.141.10.7720","article-title":"Glucagon-like peptide-1, but not glucose-dependent insulinotropic peptide, regulates fasting glycemia and nonenteral glucose clearance in mice","volume":"141","author":"Baggio","year":"2000","journal-title":"Endocrinology"},{"key":"10.1016\/j.yexcr.2016.04.007_bib10","doi-asserted-by":"crossref","first-page":"1156","DOI":"10.2337\/diabetes.49.7.1156","article-title":"Glucagon-like peptide 1 stimulates insulin gene promoter activity by protein kinase A-independent activation of the rat insulin I gene cAMP response element","volume":"49","author":"Skoglund","year":"2000","journal-title":"Diabetes"},{"key":"10.1016\/j.yexcr.2016.04.007_bib11","doi-asserted-by":"crossref","first-page":"741","DOI":"10.2337\/diabetes.49.5.741","article-title":"Insulinotropic glucagon-like peptide 1 agonists stimulate expression of homeodomain protein IDX-1 and increase islet size in mouse pancreas","volume":"49","author":"Stoffers","year":"2000","journal-title":"Diabetes"},{"key":"10.1016\/j.yexcr.2016.04.007_bib12","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1016\/j.cmet.2013.04.008","article-title":"Pharmacology, physiology, and mechanisms of incretin hormone action","volume":"17","author":"Campbell","year":"2013","journal-title":"Cell Metab."},{"key":"10.1016\/j.yexcr.2016.04.007_bib13","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1097\/01.tp.0000251379.46596.2d","article-title":"Effect of exenatide on \u03b2 cell function after islet transplantation in type 1 diabetes","volume":"83","author":"Ghofaili","year":"2007","journal-title":"Transplantation"},{"key":"10.1016\/j.yexcr.2016.04.007_bib14","doi-asserted-by":"crossref","first-page":"1658","DOI":"10.1097\/TP.0b013e31818fe448","article-title":"Long-term insulin independence and improvement in insulin secretion after supplemental islet infusion under exenatide and etanercept","volume":"86","author":"Faradji","year":"2008","journal-title":"Transplantation"},{"key":"10.1016\/j.yexcr.2016.04.007_bib15","doi-asserted-by":"crossref","first-page":"1250","DOI":"10.1111\/j.1600-6143.2008.02234.x","article-title":"Islet transplantation for brittle type 1 diabetes: The UIC protocol","volume":"8","author":"Gangemi","year":"2008","journal-title":"Am. J. Transplant."},{"key":"10.1016\/j.yexcr.2016.04.007_bib16","doi-asserted-by":"crossref","first-page":"4322","DOI":"10.1210\/en.2008-0501","article-title":"Liraglutide, a long-acting human glucagon-like peptide 1 analog, improves glucose homeostasis in marginal mass islet transplantation in mice","volume":"149","author":"Merani","year":"2008","journal-title":"Endocrinology"},{"key":"10.1016\/j.yexcr.2016.04.007_bib17","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1111\/j.1432-2277.2009.00984.x","article-title":"Liraglutide, a long-acting human glucagon-like peptide 1 analogue, improves human islet survival in culture","volume":"23","author":"Toso","year":"2010","journal-title":"Transplant Int."},{"key":"10.1016\/j.yexcr.2016.04.007_bib18","doi-asserted-by":"crossref","first-page":"2118","DOI":"10.2337\/dc12-2713","article-title":"A critical analysis of the clinical use of incretin-based therapies: are the GLP-1 therapies safe?","volume":"36","author":"Butler","year":"2013","journal-title":"Diabetes Care"},{"key":"10.1016\/j.yexcr.2016.04.007_bib19","doi-asserted-by":"crossref","first-page":"2074","DOI":"10.1007\/s00125-005-1922-0","article-title":"Islet transplantation outcomes in mice are better with fresh islets and exendin-4 treatment","volume":"48","author":"King","year":"2005","journal-title":"Diabetologia"},{"key":"10.1016\/j.yexcr.2016.04.007_bib20","doi-asserted-by":"crossref","first-page":"1650","DOI":"10.1016\/j.transproceed.2008.03.161","article-title":"Exendin-4 does not promote Beta-cell proliferation or survival during the early post-islet transplant period in mice","volume":"40","author":"Crutchlow","year":"2008","journal-title":"Transplant. Proc."},{"key":"10.1016\/j.yexcr.2016.04.007_bib21","doi-asserted-by":"crossref","first-page":"2460","DOI":"10.1021\/bm900420f","article-title":"Glucagon-like peptide-1 functionalized PEG hydrogels promote survival and function of encapsulated pancreatic beta-cells","volume":"10","author":"Lin","year":"2009","journal-title":"Biomacromolecules"},{"key":"10.1016\/j.yexcr.2016.04.007_bib22","doi-asserted-by":"crossref","first-page":"2217","DOI":"10.1089\/ten.tea.2009.0640","article-title":"Encapsulation of pancreatic islets within nano-thin functional polyethylene glycol coatings for enhanced insulin secretion","volume":"16","author":"Kizilel","year":"2010","journal-title":"Tissue Eng. Part A"},{"key":"10.1016\/j.yexcr.2016.04.007_bib23","doi-asserted-by":"crossref","first-page":"13468","DOI":"10.1073\/pnas.0600655103","article-title":"Improving function and survival of pancreatic islets by endogenous production of glucagon-like peptide 1 (GLP-1)","volume":"103","author":"Wideman","year":"2006","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.yexcr.2016.04.007_bib24","doi-asserted-by":"crossref","first-page":"1402","DOI":"10.2337\/diabetes.48.7.1402","article-title":"Pancreatic beta-cell-to-beta-cell interactions are required for integrated responses to nutrient stimuli: enhanced Ca2+ and insulin secretory responses of MIN6 pseudoislets","volume":"48","author":"Hauge-Evans","year":"1999","journal-title":"Diabetes"},{"key":"10.1016\/j.yexcr.2016.04.007_bib25","doi-asserted-by":"crossref","first-page":"41","DOI":"10.4161\/isl.3.2.14805","article-title":"Role of islet structure and cellular interactions in the control of insulin secretion","volume":"3","author":"Kelly","year":"2011","journal-title":"Islets"},{"key":"10.1016\/j.yexcr.2016.04.007_bib26","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1016\/j.bbrc.2006.03.214","article-title":"Homotypic cell contact enhances insulin but not glucagon secretion","volume":"344","author":"Brereton","year":"2006","journal-title":"Biochem Biophys. Res. Commun."},{"key":"10.1016\/j.yexcr.2016.04.007_bib27","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1007\/s12020-007-0004-0","article-title":"Islet alpha-cells do not influence insulin secretion from beta-cells through cell-cell contact","volume":"31","author":"Brereton","year":"2007","journal-title":"Endocrine"},{"key":"10.1016\/j.yexcr.2016.04.007_bib28","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1002\/dmrr.1111","article-title":"The role of glucagon- and somatostatin-secreting cells in the regulation of insulin release and beta-cell function in heterotypic pseudoislets","volume":"26","author":"Kelly","year":"2010","journal-title":"Diabetes Metab. Res. Rev."},{"key":"10.1016\/j.yexcr.2016.04.007_bib29","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1210\/endo-127-1-126","article-title":"Establishment of a pancreatic beta cell line that retains glucose-inducible insulin secretion: special reference to expression of glucose transporter isoforms","volume":"127","author":"Miyazaki","year":"1990","journal-title":"Endocrinology"},{"key":"10.1016\/j.yexcr.2016.04.007_bib30","doi-asserted-by":"crossref","first-page":"10705","DOI":"10.1016\/S0021-9258(19)50075-8","article-title":"Glucagon gene 5\u2032-flanking sequences direct expression of simian virus 40 large T antigen to the intestine, producing carcinoma of the large bowel in transgenic mice","volume":"267","author":"Lee","year":"1992","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.yexcr.2016.04.007_bib31","first-page":"2175","article-title":"Inhibition of pancreatic glucagon gene expression in mice bearing a subcutaneous glucagon-producing GLUTag transplantable tumor","volume":"6","author":"Drucker","year":"1992","journal-title":"Mol. Endocrinol."},{"key":"10.1016\/j.yexcr.2016.04.007_bib32","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1530\/JOE-12-0188","article-title":"Configuration of electrofusion-derived human insulin-secreting cell line as pseudoislets enhances functionality and therapeutic utility","volume":"214","author":"Guo-Parke","year":"2012","journal-title":"J. Endocrinol."},{"key":"10.1016\/j.yexcr.2016.04.007_bib33","first-page":"670","article-title":"Abnormal plasma glucose and insulin responses in heterozygous lean (ob\/+) mice","volume":"42","author":"Flatt","year":"1981","journal-title":"Diabetologia"},{"key":"10.1016\/j.yexcr.2016.04.007_bib34","doi-asserted-by":"crossref","first-page":"e96863","DOI":"10.1371\/journal.pone.0096863","article-title":"Incretin receptor null mice reveal key role for GLP-1 but not GIP in pancreatic beta cell adaptation to pregnancy","volume":"9","author":"Moffett","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.yexcr.2016.04.007_bib35","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/0022-1759(83)90303-4","article-title":"Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays","volume":"65","author":"Mossman","year":"1983","journal-title":"J. Immunol. Methods"},{"key":"10.1016\/j.yexcr.2016.04.007_bib36","doi-asserted-by":"crossref","first-page":"e101005","DOI":"10.1371\/journal.pone.0101005","article-title":"Role of endogenous GLP-1 and GIP in beta cell compensatory responses to insulin resistance and cellular stress","volume":"9","author":"Vasu","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.yexcr.2016.04.007_bib37","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1007\/BF00401058","article-title":"Pancreatic beta cell line MIN6 exhibits characteristics of glucose metabolism and glucose-stimulated insulin secretion similar to those of normal islets","volume":"36","author":"Ishihara","year":"1993","journal-title":"Diabetologia"},{"key":"10.1016\/j.yexcr.2016.04.007_bib38","doi-asserted-by":"crossref","first-page":"4108","DOI":"10.1210\/endo.139.10.6228","article-title":"Regulation of glucagon-like peptide-1 synthesis and secretion in the GLUTag enteroendocrine cell line","volume":"139","author":"Brubaker","year":"1998","journal-title":"Endocrinology"},{"key":"10.1016\/j.yexcr.2016.04.007_bib39","doi-asserted-by":"crossref","first-page":"31294","DOI":"10.1074\/jbc.M505657200","article-title":"Interplay of Ca2+ and cAMP signaling in the insulin-secreting MIN6 beta-cell line","volume":"280","author":"Landa","year":"2005","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.yexcr.2016.04.007_bib40","doi-asserted-by":"crossref","first-page":"2346","DOI":"10.1210\/en.2005-0396","article-title":"Ontogeny of regeneration of beta-cells in the neonatal rat after treatment with streptozotocin","volume":"147","author":"Thyssen","year":"2006","journal-title":"Endocrinology"},{"key":"10.1016\/j.yexcr.2016.04.007_bib41","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.1038\/nm.2513","article-title":"Interleukin-6 enhances insulin secretion by increasing glucagon-like peptide-1 secretion from L cells and alpha cells","volume":"17","author":"Ellingsgaard","year":"2011","journal-title":"Nat. Med."},{"key":"10.1016\/j.yexcr.2016.04.007_bib42","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.1007\/s00125-011-2080-1","article-title":"Upregulation of alpha cell glucagon-like peptide 1 (GLP-1) in Psammomys obesus--an adaptive response to hyperglycaemia?","volume":"54","author":"Hansen","year":"2011","journal-title":"Diabetologia"},{"key":"10.1016\/j.yexcr.2016.04.007_bib43","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1530\/JOE-11-0094","article-title":"Processing of proglucagon to GLP-1 in pancreatic \u03b1-cells: is this a paracrine mechanism enabling GLP-1 to act on \u03b2-cells?","volume":"211","author":"Whalley","year":"2011","journal-title":"J. Endocrinol."},{"key":"10.1016\/j.yexcr.2016.04.007_bib44","doi-asserted-by":"crossref","first-page":"e96863","DOI":"10.1371\/journal.pone.0096863","article-title":"Incretin receptor null mice reveal key role for GLP-1 but not GIP in pancreatic beta cell adaptation to pregnancy","volume":"9","author":"Moffett","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.yexcr.2016.04.007_bib45","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1097\/MPA.0b013e3181530b4","article-title":"Iterative exposure of clonal BRIN-BD11 cells to ninhydrin enables selection of robust toxin-resistant cells but with decreased gene expression of insulin secretory function","volume":"36","author":"Liu","year":"2008","journal-title":"Pancreas"},{"key":"10.1016\/j.yexcr.2016.04.007_bib46","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.bbagen.2013.08.022","article-title":"Mechanisms of toxicity by proinflammatory cytokines in a novel human pancreatic beta cell line, 1.1B4","volume":"1840","author":"Vasu","year":"2014","journal-title":"Biochim Biophys. Acta"},{"key":"10.1016\/j.yexcr.2016.04.007_bib47","doi-asserted-by":"crossref","first-page":"e87067","DOI":"10.1371\/journal.pone.0087067","article-title":"JNK1 protects against glucolipotoxicity-mediated beta-cell apoptosis","volume":"24","author":"Prause","year":"2014","journal-title":"PLOS One"},{"key":"10.1016\/j.yexcr.2016.04.007_bib48","doi-asserted-by":"crossref","first-page":"1816","DOI":"10.2337\/db09-0063","article-title":"Glucagon-like peptide-1 protects beta-cells against apoptosis by increasing the activity of an IGF-2\/IGF-1 receptor autocrine loop","volume":"58","author":"Cornu","year":"2009","journal-title":"Diabetes"},{"key":"10.1016\/j.yexcr.2016.04.007_bib49","doi-asserted-by":"crossref","first-page":"S258","DOI":"10.2337\/dc11-s230","article-title":"Incretin effects on \u03b2-cell function, replication, and mass: the human perspective","volume":"34","author":"Garber","year":"2011","journal-title":"Diabetes Care"},{"key":"10.1016\/j.yexcr.2016.04.007_bib50","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1038\/gt.2013.33","article-title":"Beneficial effects of parenteral GLP-1 delivery by cell therapy in insulin-deficient streptozotocin diabetic mice","volume":"20","author":"Vasu","year":"2013","journal-title":"Gene Ther."},{"key":"10.1016\/j.yexcr.2016.04.007_bib51","doi-asserted-by":"crossref","first-page":"1409","DOI":"10.1152\/physrev.00034.2006","article-title":"The physiology of glucagon-like peptide 1","volume":"87","author":"Holst","year":"2007","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.yexcr.2016.04.007_bib52","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1016\/j.jbiotec.2010.12.015","article-title":"Pseudoislets in stirred-suspension culture exhibit enhanced cell survival, propagation and insulin secretion","volume":"151","author":"Lock","year":"2011","journal-title":"J. Biotechnol."},{"key":"10.1016\/j.yexcr.2016.04.007_bib53","doi-asserted-by":"crossref","first-page":"80","DOI":"10.4161\/isl.3.3.15428","article-title":"Down-regulation of proliferation does not affect the secretory function of transformed \u03b2-cell lines regardless of their anatomical configuration","volume":"3","author":"Reers","year":"2011","journal-title":"Islets"},{"key":"10.1016\/j.yexcr.2016.04.007_bib54","doi-asserted-by":"crossref","first-page":"e72260","DOI":"10.1371\/journal.pone.0072260","article-title":"In vitro formation of \u03b2 cell pseudoislets using islet-derived endothelial cells","volume":"8","author":"Spelios","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.yexcr.2016.04.007_bib55","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.regpep.2010.07.078","article-title":"Evaluation of role of islet cell paracrine interactions in regulation of insulin secretion using a new heterotypicpseudoislet model","volume":"164","author":"Kelly","year":"2010","journal-title":"Regul. Pept."},{"key":"10.1016\/j.yexcr.2016.04.007_bib56","doi-asserted-by":"crossref","first-page":"3589","DOI":"10.1172\/JCI58447","article-title":"A genetically engineered human pancreatic \u03b2 cell line exhibiting glucose-inducible insulin secretion","volume":"121","author":"Ravassard","year":"2011","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.yexcr.2016.04.007_bib57","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1016\/j.cell.2014.09.040","article-title":"Generation of functional human pancreatic \u03b2 cells in vitro","volume":"159","author":"Pagliuca","year":"2014","journal-title":"Cell"},{"key":"10.1016\/j.yexcr.2016.04.007_bib58","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1016\/j.scr.2014.03.003","article-title":"Human embryonic stem cell derived islet progenitors mature inside an encapsulation device without evidence of increased biomass or cell escape","volume":"12","author":"Kirk","year":"2014","journal-title":"Stem Cell Res."},{"key":"10.1016\/j.yexcr.2016.04.007_bib59","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.biomaterials.2014.10.032","article-title":"Developing robust, hydrogel-based, nanofiber-enabled encapsulation devices (NEEDs) for cell therapies","volume":"37","author":"An","year":"2015","journal-title":"Biomaterials"},{"key":"10.1016\/j.yexcr.2016.04.007_bib60","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.phrs.2015.02.010","article-title":"Re-engineering islet cell transplantation","volume":"98","author":"Fotino","year":"2015","journal-title":"Pharmacol. Res."}],"container-title":["Experimental Cell Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S001448271630074X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S001448271630074X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,4,3]],"date-time":"2021-04-03T13:51:18Z","timestamp":1617457878000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S001448271630074X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,6]]},"references-count":60,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2016,6]]}},"alternative-id":["S001448271630074X"],"URL":"https:\/\/doi.org\/10.1016\/j.yexcr.2016.04.007","relation":{},"ISSN":["0014-4827"],"issn-type":[{"type":"print","value":"0014-4827"}],"subject":[],"published":{"date-parts":[[2016,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Functionality and antidiabetic utility of \u03b2- and L-cell containing pseudoislets","name":"articletitle","label":"Article Title"},{"value":"Experimental Cell Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.yexcr.2016.04.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}